BASEL, SWITZERLAND--The Drug Information Association (DIA) in Europe will host its 22nd Annual EuroMeeting from 8-10 March 2010 in Monaco. The EuroMeeting features more than 110 sessions across 13 themes and attracts more than 3,000 professionals from the pharmaceutical industry, contract service organisations, regulatory agencies, health ministries and academia, as well as patients and students worldwide to share experiences, participate in discussions and network with colleagues.
The opening plenary session will be held on Monday, 8 March at 13:30 with prominent debaters from the European Medicines Agency, the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS), the Swedish Association of the Pharmaceutical Industry, and industry (GlaxoSmithKline). The debaters will discuss the motion that the process to develop new medicines and bring them to patients is neither efficient nor effective. Professor Stuart Walker from the CMR International Institute for Regulatory Science will chair the debate, which will include:
• Thomas Lönngren, Executive Director, European Medicines Agency
• Eric Abadie, CHMP Chair and Member of General Directorate of the French Agency, AFSSAPS
• Richard Bergström, Director-General, Swedish Association of the Pharmaceutical Industry
• Eddie Gray, President, Pharmaceuticals Europe, GlaxoSmithKline
The EuroMeeting theme format creates a lively platform to debate the development and market access of medicines in Europe. This year’s themes include:
• Innovation
• Staying in Business: How to Make Sure You Comply with All Rules and Regulations
• Paediatric Medicines on Their Way to Patients
• Decision Making: The Key to Efficient and Effective Drug Development, Approval, and Access
• Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived
Medicines
• Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
• Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
• Taking the European Regulatory Infrastructure Forward
• Risk Management
• The Informed Patient
• eHealth
• Pharmaceutical Sciences in 2020
• Handling Clinical Trials, eSubmissions and Quality Requests
Additional EuroMeeting highlights include:
• Speakers from the European Medicines Agency, the U.S. Food and Drug Administration, the European Commission and European national competent authorities and health ministries
• More than 230 international exhibitors on one of the largest exhibition floors in Europe, showcasing their products and services
• Unparalleled multi-disciplinary networking opportunities
• 21 pre-conference tutorials led by expert faculty
• Student and Young Professional Sessions: Monday, 8 March from 09:00-12:30
• Agency Satellite Session – Focus on Small Agencies and Small Markets: Tuesday, 9 March from 18:00-19:30 highlighting presenters from the Medicines Authority Malta, Actavis Iceland and the State Medicines Control Agency Lithuania
• Japanese Regulatory Session: Wednesday, 10 March from 11:00-12:30
Networking plays an integral part in the overall EuroMeeting experience. All networking events at the EuroMeeting offer lunches, coffee breaks and evening receptions with drinks and snacks that are included in the registration fee.
About the Drug Information Association
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. For more information, visit www.diahome.org or call the DIA in Europe +41 61 225 51 51.
###
Katie McKinnon
DIA in Europe
+41 61 225 51 36
Katie.Shearer@diaeurope.org
Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski@diahome.org
Vivien Benard
Axense
33(0) 1 42 46 28 66
v.benard@axense.fr
The opening plenary session will be held on Monday, 8 March at 13:30 with prominent debaters from the European Medicines Agency, the Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS), the Swedish Association of the Pharmaceutical Industry, and industry (GlaxoSmithKline). The debaters will discuss the motion that the process to develop new medicines and bring them to patients is neither efficient nor effective. Professor Stuart Walker from the CMR International Institute for Regulatory Science will chair the debate, which will include:
• Thomas Lönngren, Executive Director, European Medicines Agency
• Eric Abadie, CHMP Chair and Member of General Directorate of the French Agency, AFSSAPS
• Richard Bergström, Director-General, Swedish Association of the Pharmaceutical Industry
• Eddie Gray, President, Pharmaceuticals Europe, GlaxoSmithKline
The EuroMeeting theme format creates a lively platform to debate the development and market access of medicines in Europe. This year’s themes include:
• Innovation
• Staying in Business: How to Make Sure You Comply with All Rules and Regulations
• Paediatric Medicines on Their Way to Patients
• Decision Making: The Key to Efficient and Effective Drug Development, Approval, and Access
• Paving the Way for Advanced Therapies: Fostering New Generations of Biotechnology-Derived
Medicines
• Challenges for Switching from Prescription to Non-Prescription Status through the Centralised Procedure
• Personalised Medicines: What Is It, Where Do We Stand, and Where Are We Going?
• Taking the European Regulatory Infrastructure Forward
• Risk Management
• The Informed Patient
• eHealth
• Pharmaceutical Sciences in 2020
• Handling Clinical Trials, eSubmissions and Quality Requests
Additional EuroMeeting highlights include:
• Speakers from the European Medicines Agency, the U.S. Food and Drug Administration, the European Commission and European national competent authorities and health ministries
• More than 230 international exhibitors on one of the largest exhibition floors in Europe, showcasing their products and services
• Unparalleled multi-disciplinary networking opportunities
• 21 pre-conference tutorials led by expert faculty
• Student and Young Professional Sessions: Monday, 8 March from 09:00-12:30
• Agency Satellite Session – Focus on Small Agencies and Small Markets: Tuesday, 9 March from 18:00-19:30 highlighting presenters from the Medicines Authority Malta, Actavis Iceland and the State Medicines Control Agency Lithuania
• Japanese Regulatory Session: Wednesday, 10 March from 11:00-12:30
Networking plays an integral part in the overall EuroMeeting experience. All networking events at the EuroMeeting offer lunches, coffee breaks and evening receptions with drinks and snacks that are included in the registration fee.
About the Drug Information Association
DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals and related products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well-being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; and Beijing, China. For more information, visit www.diahome.org or call the DIA in Europe +41 61 225 51 51.
###
Katie McKinnon
DIA in Europe
+41 61 225 51 36
Katie.Shearer@diaeurope.org
Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski@diahome.org
Vivien Benard
Axense
33(0) 1 42 46 28 66
v.benard@axense.fr